Minerva Neurosciences Statistics
Total Valuation
NERV has a market cap or net worth of $18.25 million. The enterprise value is $73.95 million.
Important Dates
The last earnings date was Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NERV has 6.99 million shares outstanding. The number of shares has increased by 40.77% in one year.
| Shares Outstanding | 6.99M |
| Shares Change (YoY) | +40.77% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.03% |
| Owned by Institutions (%) | 30.23% |
| Float | 5.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.47
| Current Ratio | 7.47 |
| Quick Ratio | 7.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -28.88% |
| Return on Capital (ROIC) | -30.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.74M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.70% in the last 52 weeks. The beta is 0.13, so NERV's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -65.70% |
| 50-Day Moving Average | 2.96 |
| 200-Day Moving Average | 4.30 |
| Relative Strength Index (RSI) | 39.62 |
| Average Volume (20 Days) | 17,547 |
Short Selling Information
The latest short interest is 12,152, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 12,152 |
| Short Previous Month | 13,675 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.66 |
Income Statement
| Revenue | n/a |
| Gross Profit | -16.19M |
| Operating Income | -26.21M |
| Pretax Income | -33.65M |
| Net Income | -33.65M |
| EBITDA | -26.21M |
| EBIT | -26.21M |
| Earnings Per Share (EPS) | -$4.44 |
Full Income StatementBalance Sheet
The company has $30.88 million in cash and $86.58 million in debt, giving a net cash position of -$55.70 million or -$7.96 per share.
| Cash & Cash Equivalents | 30.88M |
| Total Debt | 86.58M |
| Net Cash | -55.70M |
| Net Cash Per Share | -$7.96 |
| Equity (Book Value) | -44.49M |
| Book Value Per Share | -6.36 |
| Working Capital | 27.21M |
Full Balance SheetCash Flow
| Operating Cash Flow | -20.83M |
| Capital Expenditures | n/a |
| Free Cash Flow | -20.83M |
| FCF Per Share | -$2.98 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NERV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.77% |
| Shareholder Yield | -40.77% |
| Earnings Yield | -184.33% |
| FCF Yield | -114.11% |
Analyst Forecast
The average price target for NERV is $5.00, which is 91.57% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.00 |
| Price Target Difference | 91.57% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 21, 2022. It was a reverse split with a ratio of 0.125:1.
| Last Split Date | Jun 21, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.125:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |